Literature DB >> 33761957

Regulation of autophagy by microRNAs in human breast cancer.

Zhi Xiong Chong1, Swee Keong Yeap2, Wan Yong Ho3.   

Abstract

Breast cancer is the most common solid cancer that affects female population globally. MicroRNAs (miRNAs) are short non-coding RNAs that can regulate post-transcriptional modification of multiple downstream genes. Autophagy is a conserved cellular catabolic activity that aims to provide nutrients and degrade un-usable macromolecules in mammalian cells. A number of in vitro, in vivo and clinical studies have reported that some miRNAs could modulate autophagy activity in human breast cancer cells, and these would influence human breast cancer progression and treatment response. Therefore, this review was aimed to discuss the roles of autophagy-regulating miRNAs in influencing breast cancer development and treatment response. The review would first introduce autophagy types and process, followed by the discussion of the roles of different miRNAs in modulating autophagy in human breast cancer, and to explore how would this miRNA-autophagy regulatory process affect the disease progression or treatment response. Lastly, the potential applications and challenges of utilizing autophagy-regulating miRNAs as breast cancer biomarkers and novel therapeutic agents would be discussed.

Entities:  

Keywords:  Autophagy; Biomarkers; Breast cancer; Therapeutic agents; miRNAs

Year:  2021        PMID: 33761957     DOI: 10.1186/s12929-021-00715-9

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  89 in total

Review 1.  Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies.

Authors:  Weimin Fan; Jinjia Chang; Peifeng Fu
Journal:  Future Med Chem       Date:  2015-08-26       Impact factor: 3.808

Review 2.  Chemoresistance mechanisms of breast cancer and their countermeasures.

Authors:  Xiwei Ji; Yuan Lu; Huifang Tian; Xiangrui Meng; Minji Wei; William C Cho
Journal:  Biomed Pharmacother       Date:  2019-03-25       Impact factor: 6.529

Review 3.  Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy.

Authors:  Afshin Derakhshani; Zohreh Rezaei; Hossein Safarpour; Morteza Sabri; Atefeh Mir; Mohammad Amin Sanati; Fatemeh Vahidian; Ali Gholamiyan Moghadam; Ali Aghadoukht; Khalil Hajiasgharzadeh; Behzad Baradaran
Journal:  J Cell Physiol       Date:  2019-09-30       Impact factor: 6.384

Review 4.  Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations.

Authors:  Indrė Januškevičienė; Vilma Petrikaitė
Journal:  Life Sci       Date:  2019-10-24       Impact factor: 5.037

Review 5.  The Potential for microRNA Therapeutics and Clinical Research.

Authors:  Johora Hanna; Gazi S Hossain; Jannet Kocerha
Journal:  Front Genet       Date:  2019-05-16       Impact factor: 4.599

Review 6.  Ciphers and Executioners: How 3'-Untranslated Regions Determine the Fate of Messenger RNAs.

Authors:  Vinay K Mayya; Thomas F Duchaine
Journal:  Front Genet       Date:  2019-01-24       Impact factor: 4.599

7.  Development and characterisation of acquired radioresistant breast cancer cell lines.

Authors:  Mark Gray; Arran K Turnbull; Carol Ward; James Meehan; Carlos Martínez-Pérez; Maria Bonello; Lisa Y Pang; Simon P Langdon; Ian H Kunkler; Alan Murray; David Argyle
Journal:  Radiat Oncol       Date:  2019-04-15       Impact factor: 3.481

Review 8.  Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease.

Authors:  Amir Mehrgou; Mansoureh Akouchekian
Journal:  J Res Med Sci       Date:  2017-12-26       Impact factor: 1.852

Review 9.  Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.

Authors:  Rimi Hamam; Dana Hamam; Khalid A Alsaleh; Moustapha Kassem; Waleed Zaher; Musaad Alfayez; Abdullah Aldahmash; Nehad M Alajez
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

Review 10.  miR-190-5p in human diseases.

Authors:  Yue Yu; Xu-Chen Cao
Journal:  Cancer Cell Int       Date:  2019-10-07       Impact factor: 5.722

View more
  2 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  Bioinformatics Analysis Reveals the Related Role of miR-511-5p in the Progression of Breast Cancer.

Authors:  Teng Wang; Jinquan Liu; Rui Zhong; Yidan Zhang; Zhenxuan Sun; Jutao Li; Gang Hu; Li Sun; Jintao Liu
Journal:  J Healthc Eng       Date:  2022-02-10       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.